Literature DB >> 16230784

Follow up of patients with postpartum thyroiditis: a population-based study.

Farzaneh Sarvghadi1, Mehdi Hedayati, Yadollah Mehrabi, Fereidoun Azizi.   

Abstract

In this survey we studied the prevalence of permanent hypothyroidism and prognostic factors for its occurrence 3-5 yr after postpartum thyroiditis (PPT); 54 of 120 women with PPT and 50 of 920 healthy women from among 1,040 women followed 4-5 yr earlier for PPT were recalled. Demographic information, signs, and symptoms of thyroid disorders and results of physical exams were documented. Serum T3, T4, RT3U, TSH, and anti-thyroperoxidase (anti-TPO ab) and anti-thyro-gluboline (anti-Tg ab) antibodies were measured. Twenty-two percent of the cases and four percent of the control group had permanent hypothyroidism, p<0.01. Based on the TSH level we divided the case group into two subgroups: PPT-Hypothyroidism (PPT-Hypo) and PPT-Eutyhroidism (PPT-EU); PPT-Hypo had greater titer of anti-TPO ab than PPT-Eu (437+/-283 vs 126+/-221 IU/mL, p<0.001). Comparison of mean peak serum TSH level and anti-TPO ab during the postpartum thyroiditis phase between PPT-Hypo and PPT-Eu in the case group was significant (56+/- 24 vs 23+/- 28 mU/L, p<0.001, and 1960+/-1270 vs 640+/-959 IU/L, p<0.001, respectively). Results of this survey show a high prevalence of permanent hypothyroidism following PPT in Tehran. High titers of anti-TPOAb and TSH levels at postpartum period are prognostic factors for occurrence of permanent hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230784     DOI: 10.1385/ENDO:27:3:279

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  20 in total

Review 1.  Recognizing, understanding, and treating postpartum thyroiditis.

Authors:  A Stagnaro-Green
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

2.  Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity.

Authors:  L D Premawardhana; A B Parkes; F Ammari; R John; C Darke; H Adams; J H Lazarus
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

3.  In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans.

Authors:  E J Giltay; J C Fonk; B M von Blomberg; H A Drexhage; C Schalkwijk; L J Gooren
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

Review 4.  Thyroid disease in relation to pregnancy: a decade of change.

Authors:  J H Lazarus; A Kokandi
Journal:  Clin Endocrinol (Oxf)       Date:  2000-09       Impact factor: 3.478

5.  Postpartum thyroiditis: epidemiology and clinical evolution in a nonselected population.

Authors:  A Lucas; E Pizarro; M L Granada; I Salinas; M Foz; A Sanmarti
Journal:  Thyroid       Date:  2000-01       Impact factor: 6.568

6.  Post-partum thyroiditis in a mediterranean population: a prospective study of a large cohort of thyroid antibody positive women at the time of delivery.

Authors:  M Kita; D G Goulis; A Avramides
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

7.  Autoimmune thyroid dysfunction in the postpartum period.

Authors:  R Jansson; S Bernander; A Karlsson; K Levin; G Nilsson
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

8.  Long term follow-up and HLA association in patients with postpartum hypothyroidism.

Authors:  J Tachi; N Amino; H Tamaki; M Aozasa; Y Iwatani; K Miyai
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

9.  A long-term follow-up of postpartum thyroiditis.

Authors:  S Othman; D I Phillips; A B Parkes; C J Richards; B Harris; H Fung; C Darke; R John; R Hall; J H Lazarus
Journal:  Clin Endocrinol (Oxf)       Date:  1990-05       Impact factor: 3.478

10.  Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis.

Authors:  L Chiovato; P Bassi; F Santini; C Mammoli; P Lapi; P Carayon; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.